Bowen Hanes & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.91M Sell
36,439
-1,985
-5% -$462K 0.22% 62
2025
Q4
$7.95M Sell
38,424
-170
-0.4% -$33.6K 0.2% 68
2025
Q3
$7.16M Buy
38,594
+350
+0.9% +$60K 0.18% 68
2025
Q2
$5.84M Sell
38,244
-310
-0.8% -$47.7K 0.15% 69
2025
Q1
$6.39M Sell
38,554
-2,092
-5% -$327K 0.18% 72
2024
Q4
$5.88M Sell
40,646
-335
-0.8% -$51.9K 0.16% 72
2024
Q3
$6.64M Sell
40,981
-2,750
-6% -$438K 0.17% 71
2024
Q2
$6.39M Sell
43,731
-7,233
-14% -$1.08M 0.18% 71
2024
Q1
$8.06M Sell
50,964
-212,121
-81% -$33.8M 0.23% 66
2023
Q4
$41.2M Sell
263,085
-12,415
-5% -$1.9M 1.24% 40
2023
Q3
$42.9M Sell
275,500
-1,495
-0.5% -$247K 1.44% 38
2023
Q2
$45.8M Buy
276,995
+1,048
+0.4% +$169K 1.47% 35
2023
Q1
$42.8M Sell
275,947
-23,620
-8% -$3.81M 1.47% 34
2022
Q4
$52.9M Buy
299,567
+3,554
+1% +$614K 1.88% 20
2022
Q3
$48.4M Buy
296,013
+4,255
+1% +$720K 1.87% 22
2022
Q2
$51.8M Buy
291,758
+13,048
+5% +$2.32M 1.88% 23
2022
Q1
$49.4M Sell
278,710
-3,315
-1% -$564K 1.47% 28
2021
Q4
$48.2M Sell
282,025
-77,669
-22% -$12.7M 1.36% 31
2021
Q3
$58.1M Sell
359,694
-2,792
-0.8% -$476K 1.78% 20
2021
Q2
$59.7M Sell
362,486
-3,980
-1% -$659K 1.82% 20
2021
Q1
$60.2M Buy
366,466
+1,018
+0.3% +$165K 1.92% 15
2020
Q4
$57.5M Buy
365,448
+735
+0.2% +$108K 1.91% 17
2020
Q3
$54.3M Buy
364,713
+2,639
+0.7% +$390K 1.96% 17
2020
Q2
$50.9M Sell
362,074
-3,435
-0.9% -$501K 2.05% 14
2020
Q1
$47.9M Buy
365,509
+3,077
+0.8% +$437K 2.35% 4
2019
Q4
$52.9M Buy
362,432
+37,290
+11% +$5.06M 2.18% 8
2019
Q3
$42.1M Buy
325,142
+840
+0.3% +$111K 1.79% 24
2019
Q2
$45.2M Buy
324,302
+760
+0.2% +$105K 1.94% 18
2019
Q1
$45.2M Buy
323,542
+14,882
+5% +$1.99M 2% 15
2018
Q4
$39.8M Sell
308,660
-928
-0.3% -$129K 2.01% 14
2018
Q3
$42.8M Buy
309,588
+1,860
+0.6% +$247K 1.88% 14
2018
Q2
$37.3M Buy
307,728
+553
+0.2% +$69K 1.74% 18
2018
Q1
$39.4M Sell
307,175
-125
-0% -$16.9K 1.82% 13
2017
Q4
$42.9M Sell
307,300
-4,271
-1% -$595K 1.92% 10
2017
Q3
$40.5M Sell
311,571
-238
-0.1% -$31.6K 1.91% 10
2017
Q2
$41.2M Sell
311,809
-2,543
-0.8% -$324K 2.02% 4
2017
Q1
$39.2M Buy
314,352
+3,687
+1% +$440K 1.96% 5
2016
Q4
$35.8M Sell
310,665
-40,215
-11% -$4.65M 1.92% 7
2016
Q3
$41.4M Sell
350,880
-5,333
-1% -$647K 2.2% 1
2016
Q2
$43.2M Sell
356,213
-345
-0.1% -$39.2K 2.34% 1
2016
Q1
$38.6M Buy
356,558
+15,535
+5% +$1.61M 2.13% 3
2015
Q4
$35M Buy
341,023
+22,124
+7% +$2.22M 1.96% 5
2015
Q3
$29.8M Buy
318,899
+6,320
+2% +$611K 1.71% 13
2015
Q2
$30.5M Sell
312,579
-3,806
-1% -$381K 1.51% 18
2015
Q1
$31.8M Buy
316,385
+4,211
+1% +$428K 1.53% 18
2014
Q4
$32.6M Buy
312,174
+14,855
+5% +$1.57M 1.6% 12
2014
Q3
$31.7M Sell
297,319
-31,270
-10% -$3.24M 1.55% 12
2014
Q2
$34.4M Buy
328,589
+5,150
+2% +$521K 1.6% 11
2014
Q1
$31.8M Buy
323,439
+435
+0.1% +$40.3K 1.54% 13
2013
Q4
$29.6M Sell
323,004
-16,791
-5% -$1.55M 1.44% 21
2013
Q3
$29.5M Buy
339,795
+7,250
+2% +$650K 1.51% 15
2013
Q2
$28.6M Buy
+332,545
New +$28.2M 1.53% 18

Other funds holding JNJ

Bowen Hanes & Co's JNJ Position: Q1 2026 in Review

Bowen Hanes & Co reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q1 2026, selling an estimated $462K and leaving 36,439 shares worth $8.91M. The position accounts for 0.22% of the portfolio, ranked #62.

Bowen Hanes & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.2M in Q1 2021. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bowen Hanes & Co held 36,439 shares of Johnson & Johnson worth $8.91M as of Q1 2026.
  • Bowen Hanes & Co sold 1,985 Johnson & Johnson shares in Q1 2026, an estimated $462K.
  • Johnson & Johnson made up 0.22% of Bowen Hanes & Co's portfolio in Q1 2026, its #62 holding.
  • Bowen Hanes & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Bowen Hanes & Co's Johnson & Johnson position peaked at $60.2M in Q1 2021.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bowen Hanes & Co's 13F filing for Q1 2026, filed 14 May 2026.